Medicare Enrolled

Dr. Sanjiv Faldu, M.D.

Cardiovascular Disease · Red Bluff, CA
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Speaking/Promotional
2526 SISTER MARY COLUMBA DR FL 1, Red Bluff, CA 96080
5305286150
In practice since 2005 (20 years)
NPI: 1619973393 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Faldu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faldu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Faldu

Dr. Sanjiv Faldu is a cardiovascular disease specialist in Red Bluff, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Faldu performed 5,303 Medicare services across 3,574 unique beneficiaries.

Between the years covered by Open Payments, Dr. Faldu received a total of $13,759 from 32 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Faldu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in CA $13,759 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,303
Medicare services
Top 18% in CA for cardiovascular disease
3,574
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~265 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
1,160 $43 $88
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
708 $66 $143
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
677 $20 $229
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
514 $6 $23
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
475 $10 $47
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
386 $281 $1,651
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
310 $133 $626
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision.
227 $17 $61
Exercise or drug-induced heart stress test with ECG
A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate.
227 $21 $108
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
130 $48 $210
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
123 $67 $211
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
79 $62 $145
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
65 $79 $213
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
64 $25 $83
External EKG monitoring, 8-15 days
Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm.
39 $20 $67
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
38 $100 $271
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results.
28 $8 $40
Continuous external EKG monitoring, 8-15 days
This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days.
23 $8 $37
Continuous EKG monitoring review, 48-7 days
Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days.
17 $19 $61
Follow-up heart ultrasound
An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress.
13 $20 $272
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
53.7% medium
40.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,759
Total received (2018-2024)
Avg $1,966/year across 7 years
Top 23% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,954 (65.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,805 (34.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,399
2023
$2,285
2022
$805
2021
$659
2020
$914
2019
$4,960
2018
$737

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$2,566
Boston Scientific Corporation
$226
CARDIVA MEDICAL, INC.
$161
Novartis Pharmaceuticals Corporation
$85
Edwards Lifesciences Corporation
$59
AstraZeneca Pharmaceuticals LP
$51
Philips North America LLC
$49
Kiniksa Pharmaceuticals International, plc
$45
Amgen Inc.
$35
ABIOMED
$23
ATRICURE, INC.
$22
E.R. Squibb & Sons, L.L.C.
$21
Esperion Therapeutics, Inc.
$21
SANOFI-AVENTIS U.S. LLC
$19
Tactile Systems Technology Inc
$17
Top 3 companies account for 86.9% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9,665
Abbott Laboratories
$752
Bayer HealthCare Pharmaceuticals Inc.
$423
Boston Scientific Corporation
$348
United Therapeutics Corporation
$348
Esperion Therapeutics, Inc.
$310
Novartis Pharmaceuticals Corporation
$227
Amgen Inc.
$178
Edwards Lifesciences Corporation
$167
CARDIVA MEDICAL, INC.
$161
Medtronic Vascular, Inc.
$141
Janssen Pharmaceuticals, Inc
$128
ABIOMED
$121
AstraZeneca Pharmaceuticals LP
$116
Merck Sharp & Dohme LLC
$103
BIOTRONIK INC.
$59
E.R. Squibb & Sons, L.L.C.
$58
iRhythm Technologies, Inc.
$53
Philips North America LLC
$49
Kiniksa Pharmaceuticals International, plc
$45
Actelion Pharmaceuticals US, Inc.
$45
ATRICURE, INC.
$41
PFIZER INC.
$39
Kiniksa Pharmaceuticals, Ltd.
$35
Merck Sharp & Dohme Corporation
$34
SANOFI-AVENTIS U.S. LLC
$19
Chiesi USA, Inc.
$18
Lilly USA, LLC
$17
Tactile Systems Technology Inc
$17
AltaThera Pharmaceuticals LLC
$16
Lexicon Pharmaceuticals, Inc.
$14
Amarin Pharma Inc.
$13
Top 3 companies account for 78.8% of all-time payments
Associated products mentioned in payments ›
(CM9) Amb Mon & Diag Und · ATRICLIP LAA EXCLUSION SYSTEM · Adempas · Arcalyst · Assurity Pacemaker · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CardioMEMS HF System · CareLink Express · Claria MRI · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · Flexitouch Plus · GENERAL - THERAPIES · HeartMate 3 Left Ventricular Dev · Impella · Inpefa · JARDIANCE · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LifeVest · MULTAQ · Merlin Connectivity and Remote · NEXLETOL · NEXLIZET · NONE · OPSUMIT · ORENITRAM · Quadra Assura CRT Defibrillator · Repatha · Sotalol Hydrochloride · VERQUVO · Vascepa · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.

Looking for a cardiovascular disease specialist in Red Bluff?
Compare cardiologists in the Red Bluff area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
2
Per 100K population
3.1
County median income
$61,834
Nearest hospital
ST ELIZABETH COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Faldu is a cardiac imaging specialist, with above-average Medicare volume (top 18% in CA), with speaking/promotional industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Faldu experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Faldu performed 1,160 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faldu receive payments from pharmaceutical companies?
Yes. Dr. Faldu received a total of $13,759 from 32 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faldu's costs compare to other cardiologists in Red Bluff?
Dr. Faldu's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faldu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →